Eyes On Cataract & Refractive is back August 15!
Discover the latest surgical advancements from leading ophthalmologists reshaping the cataract and refractive landscape, and earn up to 3.5 CME credits live! Reserve your spot to join experts like Eric Donnenfeld, MD, and Neel S. Vaidya, MD, MPH, for candid discussions on presbyopic and EDOF IOLs, ICL sizing, corneal refractive surgery, light-adjustable lenses, and ocular surface optimization across 7 virtual clinical sessions.
New Content
Pilocarpine: How Lower-Dose Options Mitigate Adverse Effects with Patient Handout
How the New 5-Year SYFOVRE Data May Impact GA Treatment
Sit down with Drs. Singh and Dhoot as they review 5-year GALE trial data on SYFOVRE (pegcetacoplan) for the treatment of geographic atrophy (GA).
Dry Eye Management in Clinical Practice
Consider a clinical framework for efficiently identifying and managing dry eye in a busy optometric practice.
The Importance of Early Pharmacologic Intervention in Dry Eye Treatment
Join Preeya K. Gupta, MD, and Cory Lappin, OD, FAAO, as they discuss dry eye intervention, focusing on the importance of early pharmacological treatment.
Topics
Clinical Pearls for Utilizing and Interpreting Meibography in Exams
Join Drs. Dierker and Koetting to review how optometrists can integrate meibography into their practice, interpret the imaging, and counsel patients on MGD.
Harrow relaunches biosimilar Byooviz in the US
With commercial rights acquired from Samsung Bioepis, the FDA-approved interchangeable therapy to Lucentis is indicated for the treatment of wet AMD, RVO, and mCNV.
Genentech's sBLA for subcutaneous TED therapy receives FDA priority review
Enspryng (satralizumab) has the potential to become the first at-home SC therapy to target the underlying disease with a novel mechanism of action.
IVT injections lead to low endophthalmitis rates
Rare but vision-threatening infections after injections remain uncommon, with new data showing no added risk from newer anti-VEGF agents.
Early Detection of Vision Impairments for Children Act: What ODs Should Know
Review what optometrists need to know about the Early Detection of Vision Impairments for Children (EDVI) Act and how to support this important legislation.
The Link Between Autoimmune Disorders and Dry Eye Disease
Review diagnostic tools and treatment options for patients with autoimmune-related dry eye disease that improve clinical signs and symptoms.
Pilocarpine: How Lower-Dose Options Mitigate Adverse Effects with Patient Handout
Sit down with Drs. Schaeffer and Huegel as they discuss how low-dose pilocarpine eye drops offer presbyopic patients an alternative with fewer side effects and reliable near-vision improvement.
Clinical Specialties
How the New 5-Year SYFOVRE Data May Impact GA Treatment
Staff-Driven Contact Lens Sales: Turning Technicians Into Revenue Generators
Review the state and future of the soft contact lens market and how optometrists can empower practice staff to increase contact lens sales.
Collaborative Care Within the Industry: What Does It Mean To Be A KOL
Join Drs. Lang, Leung, and Dang as they discuss what it means to be a KOL and how to engage with industry with clinical integrity.
How Ophthalmologists Can Use AI for Optimizing Their Practice
Sit down with Dr. De Rojas as he discusses the current and future impact of artificial intelligence (AI) in ophthalmology and how he uses AI in his practice.
Careers
A Look at Optometry Salaries in 2026 with Calculator
Information Blocking: The Next Compliance Crisis for ODs
The Ultimate Guide to Continuing Education For Optometrists
Featured Writers
Become a Writer
Ophthalmic Medical Education Summit 2025: Optimizing Astigmatism Management With ZEISS VERACITY
Dr. Brandon Ayres, MD, and Julie Schallhorn, MD, MS, discuss optimizing astigmatism management in cataract surgery with VERACITY Surgery Planner.
